MedTrace Logo

Combi-elastography Assessment of Chronic Liver Disease Multi-center Study

NCT04625166 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 880

Last updated 2021-01-12

No results posted yet for this study

Summary

HITACH developed a new combi-elastography imaging technology combines shear wave imaging and strain imaging technology. In the study, not only the F index which is related to the stage of liver fibrosis can be obtained, but also the A index which is related to the stage of hepatitis can be obtained, which can not be obtained by other ultrasound devices.

Conditions

  • Non Alcoholic Fatty Liver
  • Hepatitis B
  • Drug-induced Liver Injury

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Ping Liang, Doctor · Chinese PLA General Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-01-01
Completion
2022-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04625166 on ClinicalTrials.gov